chlorzoxazone has been researched along with charybdotoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridges, RJ; Devor, DC; Gerlach, AC; Gondor, M; Pilewski, JM; Singh, AK | 1 |
| Cuthbert, AW; Keogh, J; MacVinish, LJ | 1 |
| Ishikawa, T; Ito, Y; Kondo, M; Kume, H; Nakayama, S; Sato, S; Shimokata, K; Son, M | 1 |
3 other study(ies) available for chlorzoxazone and charybdotoxin
| Article | Year |
|---|---|
Stimulation of Cl(-) secretion by chlorzoxazone.
Topics: Amiloride; Anions; Bronchi; Bumetanide; Cell Membrane; Cells, Cultured; Charybdotoxin; Chlorine; Chlorzoxazone; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Interactions; Epithelium; Glyburide; Humans; Isoproterenol; Nasal Mucosa; Nystatin; Potassium Channel Blockers; Rubidium; Zoxazolamine | 2000 |
EBIO, an agent causing maintained epithelial chloride secretion by co-ordinate actions at both apical and basolateral membranes.
Topics: Animals; Benzimidazoles; Calcium Channel Agonists; Cell Polarity; Charybdotoxin; Chlorides; Chlorzoxazone; Colforsin; Colon; Cyclic AMP; Cystic Fibrosis; Dose-Response Relationship, Drug; In Vitro Techniques; Intestinal Mucosa; Mice; Muscle Relaxants, Central; Nasal Mucosa; Potassium Channels | 2001 |
ATP release triggered by activation of the Ca2+-activated K+ channel in human airway Calu-3 cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Benzimidazoles; Bumetanide; Calcium; Cell Size; Charybdotoxin; Chlorzoxazone; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Cytosol; Epithelial Cells; Glyburide; Humans; Ionomycin; Isoproterenol; Luciferases; Lung; Potassium Channels, Calcium-Activated; Potassium Chloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1 | 2004 |